Patient-reported outcomes in the Translational Breast Cancer Research Consortium

Deborah J. Bowen; Eileen H. Shinn; Sophie Gregrowski; Gretchen Kimmick; Laura S. Dominici; Elizabeth S. Frank; Karen Lisa Smith; Gabrielle Rocque; Kathryn J. Ruddy; Teri Pollastro; Michelle Melisko; Tarah J. Ballinger; Oluwadamilola M. Fayanju; Antonio C. Wolff

doi:10.1002/cncr.32615

Patient-reported outcomes in the Translational Breast Cancer Research Consortium

Deborah J. Bowen, Eileen H. Shinn, Sophie Gregrowski, Gretchen Kimmick, Laura S. Dominici, Elizabeth S. Frank, Karen Lisa Smith, Gabrielle Rocque, Kathryn J. Ruddy, Teri Pollastro, Michelle Melisko, Tarah J. Ballinger, Oluwadamilola M. Fayanju, Antonio C. Wolff

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Members of the Translational Breast Cancer Research Consortium conducted an expert-driven literature review to identify a list of domains and to evaluate potential measures of these domains for inclusion in a list of preferred measures. Measures were included if they were easily available, free of charge, and had acceptable psychometrics based on published peer-reviewed analyses. A total of 22 domains and 52 measures were identified during the selection process. Taken together, these measures form a reliable and validated list of measurement tools that are easily available and used in multiple cancer trials to assess patient-reported outcomes in relevant patients.

Original language	English (US)
Pages (from-to)	922-930
Number of pages	9
Journal	Cancer
Volume	126
Issue number	5
DOIs	https://doi.org/10.1002/cncr.32615
State	Published - Mar 1 2020

Keywords

breast cancer consortium
breast cancer treatment
clinical trials
patient-reported outcomes
translational clinical judgements

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.32615

Cite this

@article{43c15632a7534944ae9fed9ffeebdccb,

title = "Patient-reported outcomes in the Translational Breast Cancer Research Consortium",

abstract = "Members of the Translational Breast Cancer Research Consortium conducted an expert-driven literature review to identify a list of domains and to evaluate potential measures of these domains for inclusion in a list of preferred measures. Measures were included if they were easily available, free of charge, and had acceptable psychometrics based on published peer-reviewed analyses. A total of 22 domains and 52 measures were identified during the selection process. Taken together, these measures form a reliable and validated list of measurement tools that are easily available and used in multiple cancer trials to assess patient-reported outcomes in relevant patients.",

keywords = "breast cancer consortium, breast cancer treatment, clinical trials, patient-reported outcomes, translational clinical judgements",

author = "Bowen, {Deborah J.} and Shinn, {Eileen H.} and Sophie Gregrowski and Gretchen Kimmick and Dominici, {Laura S.} and Frank, {Elizabeth S.} and Smith, {Karen Lisa} and Gabrielle Rocque and Ruddy, {Kathryn J.} and Teri Pollastro and Michelle Melisko and Ballinger, {Tarah J.} and Fayanju, {Oluwadamilola M.} and Wolff, {Antonio C.}",

note = "Publisher Copyright: {\textcopyright} 2019 American Cancer Society",

year = "2020",

month = mar,

day = "1",

doi = "10.1002/cncr.32615",

language = "English (US)",

volume = "126",

pages = "922--930",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Patient-reported outcomes in the Translational Breast Cancer Research Consortium

AU - Bowen, Deborah J.

AU - Shinn, Eileen H.

AU - Gregrowski, Sophie

AU - Kimmick, Gretchen

AU - Dominici, Laura S.

AU - Frank, Elizabeth S.

AU - Smith, Karen Lisa

AU - Rocque, Gabrielle

AU - Ruddy, Kathryn J.

AU - Pollastro, Teri

AU - Melisko, Michelle

AU - Ballinger, Tarah J.

AU - Fayanju, Oluwadamilola M.

AU - Wolff, Antonio C.

PY - 2020/3/1

Y1 - 2020/3/1

N2 - Members of the Translational Breast Cancer Research Consortium conducted an expert-driven literature review to identify a list of domains and to evaluate potential measures of these domains for inclusion in a list of preferred measures. Measures were included if they were easily available, free of charge, and had acceptable psychometrics based on published peer-reviewed analyses. A total of 22 domains and 52 measures were identified during the selection process. Taken together, these measures form a reliable and validated list of measurement tools that are easily available and used in multiple cancer trials to assess patient-reported outcomes in relevant patients.

AB - Members of the Translational Breast Cancer Research Consortium conducted an expert-driven literature review to identify a list of domains and to evaluate potential measures of these domains for inclusion in a list of preferred measures. Measures were included if they were easily available, free of charge, and had acceptable psychometrics based on published peer-reviewed analyses. A total of 22 domains and 52 measures were identified during the selection process. Taken together, these measures form a reliable and validated list of measurement tools that are easily available and used in multiple cancer trials to assess patient-reported outcomes in relevant patients.

KW - breast cancer consortium

KW - breast cancer treatment

KW - clinical trials

KW - patient-reported outcomes

KW - translational clinical judgements

UR - http://www.scopus.com/inward/record.url?scp=85075487393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075487393&partnerID=8YFLogxK

U2 - 10.1002/cncr.32615

DO - 10.1002/cncr.32615

M3 - Comment/debate

C2 - 31743427

AN - SCOPUS:85075487393

SN - 0008-543X

VL - 126

SP - 922

EP - 930

JO - Cancer

JF - Cancer

IS - 5

ER -

Patient-reported outcomes in the Translational Breast Cancer Research Consortium

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this